As a startup in life sciences, you use your research to create world-changing impact. In most cases, there may be a need for larger investments and longer timeline to achieve sales and scale globally. How do you find the right investors who can bring you contacts, funds, and industry expertise?

Listen to our July 23rd session to gain insights in how to grow and scale your life science startup through the angel investor network. Mahzad Sharifahmadian, Life Sciences Manager at District 3, will be joined by Ozan Isinak, President for the Keiretsu Forum Canada, the world’s largest angel investment network operating 53 chapters on 4 continents. In addition to the role of investor, Keiretsu Forum and its members facilitate access to talent, technology, and resources needed to build a successful venture.

Although Keiretsu Forum has a portfolio of investments in a diverse range of companies, they are dedicated to devoting 30% of their portfolio to guiding and providing mentorship for early stage life sciences companies. In 2018, Keiretsu Forum made their first investment in a Montreal-based company, Laurent Pharmaceuticals Inc., a clinical stage company focusing on chronic inflammatory diseases.

As an expert with over 25 years of international experience in angel investment, venture capital and private equity sectors, Ozan Isinak will be joined us to discuss:
- His experience investing in life sciences startups in Canada
- How Venture Capitalists and angel investors view valuations, due diligence, scalability, iteration, and exit strategies particularly in life sciences startups
- What it takes to fund your startup through investors and the particularities for life science startups.